Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Wednesday, May 31, 2023
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
admin
-
May 17, 2023
Latest Pharma-News
FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause
admin
-
May 17, 2023
Latest Pharma-News
Farxiga extended in US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients
admin
-
May 9, 2023
Latest Pharma-News
BMS Receives EC Approval for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy
admin
-
May 8, 2023
Latest Pharma-News
Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
admin
-
May 8, 2023
Latest Pharma-News
FDA Takes Additional Steps to Advance Decentralized Clinical Trials
admin
-
May 4, 2023
0
Latest Pharma-News
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
admin
-
May 4, 2023
0
Latest Pharma-News
Bayer and Cat Creek Energy Sign Landmark Renewable Energy Deal
admin
-
May 4, 2023
0
Latest Pharma-News
Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines
admin
-
May 4, 2023
0
Latest Pharma-News
XTANDI® plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide
admin
-
April 30, 2023
0
Latest Pharma-News
Update on FDA Advisory Committee vote on Lynparza plus abiraterone for metastatic castration-resistant prostate cancer
admin
-
April 30, 2023
0
Latest Pharma-News
EMA validates marketing authorisation application for Jemperli plus chemotherapy for dMMR/MSI-H primary advanced or recurrent endometrial cancer
admin
-
April 25, 2023
0
Latest Pharma-News
FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines
admin
-
April 21, 2023
0
Latest Pharma-News
Bayer’s New data from pivotal studies with aflibercept 8 mg
admin
-
April 21, 2023
0
Latest Pharma-News
FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation
admin
-
April 19, 2023
0
Latest Pharma-News
Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi
admin
-
April 11, 2023
0
Latest Pharma-News
FDA Accepts Pfizer’s sNDA for BRAFTOVI + MEKTOVI
admin
-
April 10, 2023
0
1
2
3
...
143
Page 1 of 143
- Advertisment -
Most Read
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
May 17, 2023
FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause
May 17, 2023
Farxiga extended in US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients
May 9, 2023
BMS Receives EC Approval for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy
May 8, 2023